YENNY PORRATA: Open Payments
NPI 1316453020 · MIAMI, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$774 in 37 payments from 10 companies in 2025. Trend: 2023 $2,100 · 2024 $2,166 · 2025 $774
Food & beverage: $774
| Company | Payments | Amount |
|---|---|---|
| Axsome Therapeutics, Inc. | 8 | $146 |
| Vanda Pharmaceuticals Inc. | 5 | $129 |
| Lundbeck LLC | 4 | $99 |
| ABBVIE INC. | 5 | $95 |
| Alkermes, Inc. | 4 | $72 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $60 |
| Almatica Pharma LLC | 3 | $57 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $48 |
| Otsuka America Pharmaceutical, Inc. | 2 | $41 |
| E.R. Squibb & Sons, L.L.C. | 1 | $27 |
Products named: Auvelity, REXULTI, VRAYLAR, FANAPT, ARISTADA, TRINTELLIX, LOREEV XR, CAPLYTA.
Industry payments across FL — which companies pay providers there.
